HOW SARCLISA WORKS

SARCLISA: A targeted immunotherapy

Designed to find and bind

SARCLISA is not chemotherapy. It is a type of targeted immunotherapy that is able to “find and bind” to myeloma cells. SARCLISA 
works together with your immune system to help destroy myeloma cells.

  • An icon of a SARCLISA molecule.SARCLISA
  • An icon of an immune system cell.Immune system cell
  • An icon of a myeloma cell.Myeloma cell
A SARCLISA molecule binds to a myeloma cell, exposing it to an immune system cell.

SARCLISA finds and binds to myeloma cells and exposes them for elimination by your immune system.

A SARCLISA molecule boosts immune system cells.

SARCLISA helps boost your immune system, making it harder for myeloma cells to survive.

A SARCLISA molecule kills a myeloma cell.

SARCLISA directly kills
myeloma cells.

Watch the story of how SARCLISA works to help fight multiple myeloma

SARCLISA is not chemotherapy.

SARCLISA is a targeted immunotherapy.

An icon of an Erlenmeyer flask.

Explore our latest Phase 3 trial
results for SARCLISA.

Latest SARCLISA data white arrow
An icon of an envelope.

Sign up to get the latest
updates about SARCLISA.

Sign up today
A mature African American couple looks at a camera against a mountain backdrop.
Patient representation.